Single Point Partners’s AbbVie ABBV Stock Holding History

Single Point Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$222K	Buy	+883	New	+$190K	0.04%	94
2026 Q1	–	Sell	-912	Closed	-$208K	–	84
2025 Q4	$208K	Hold	912	–	–	0.04%	84
2025 Q3	$211K	Buy	+912	New	+$186K	0.04%	85
2025 Q2	–	Sell	-1,058	Closed	-$222K	–	89
2025 Q1	$222K	Buy	+1,058	New	+$206K	0.05%	83
2023 Q3	–	Sell	-1,903	Closed	-$256K	–	78
2023 Q2	$256K	Sell	1,903 -439	-19%	-$64.4K	0.35%	51
2023 Q1	$373K	Buy	2,342 +176	+8%	+$26.9K	0.08%	91
2022 Q4	$350K	Buy	2,166 +5	+0.2%	+$767	0.08%	92
2022 Q3	$290K	Buy	2,161 +272	+14%	+$39K	0.08%	92
2022 Q2	$289K	Buy	1,889 +548	+41%	+$83.7K	0.08%	90
2022 Q1	$217K	Buy	+1,341	New	+$195K	0.06%	108

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Single Point Partners's ABBV Position: Q2 2026 in Review

Single Point Partners opened a new position in AbbVie (ABBV) in Q2 2026: 883 shares worth $222K. The stake represents 0.04% of the portfolio and ranks #94 among its holdings. This is a return to the name: Single Point Partners previously reported a position in ABBV as recently as Q4 2025.

Single Point Partners first reported a position in ABBV in Q1 2022 and has held it in 10 quarters since. The position peaked at $373K in Q1 2023. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Single Point Partners held 883 shares of AbbVie worth $222K as of Q2 2026.
AbbVie was a new Single Point Partners position in Q2 2026.
AbbVie made up 0.04% of Single Point Partners's portfolio in Q2 2026, its #94 holding.
Single Point Partners first reported a position in AbbVie in Q1 2022 and has held it in 10 quarters since.
Single Point Partners's AbbVie position peaked at $373K in Q1 2023.
4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Single Point Partners's 13F filing for Q2 2026, filed 16 Jul 2026.